Wide Ranks

BCTX

BriaCell Therapeutics Corp.

0.8423

Top Statistics
Market Cap 31 M Forward PE -2.16 Revenue Growth 0.00 %
Current Ratio 0.49 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.4280 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 862089 Total Cash Per Share 0.0470 Total Debt
Total Debt To Equity Current Ratio 0.49 Book Value Per Share -0.1300
All Measures
Short Ratio 56.00 % Message Board Id finmb_262266102 Fax 604-921-1898
Shares Short Prior Month 727572 City West Vancouver Uuid 4582bc39-2d8c-30ab-8663-2245a7a6ffd9
Previous Close 0.7471 First Trade Date Epoch Utc 1 B Book Value -0.1300
Beta 1.82 Volume 1 M Last Split Date 1 B
Fifty Two Week Low 0.4600 Total Cash Per Share 0.0470 Shares Short Previous Month Date 1 B
Target Median Price 15.00 Max Age 86400 Sand P52 Week Change 0.3133
Target Mean Price 15.00 Net Income To Common -4791466 Short Percent Of Float 0.0166
Implied Shares Outstanding 36 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 1 M Average Volume10days 1 M Total Cash 862089
Next Fiscal Year End 1 B Held Percent Insiders 0.1960 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 0.7471
Target Low Price 15.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.8014
Open 0.7563 Free Cashflow -10834774 State BC
Dividend Yield 0.00 % Return On Assets -1.26 Time Zone Short Name EST
Trailing Eps -0.2900 Day Low 0.7400 Address1 Bellevue Centre
Shares Outstanding 36 M Price Hint 4 Target High Price 15.00
Website https://briacell.com 52 Week Change -0.8412 Average Volume 5 M
Forward Eps -0.3900 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 21.40 % Last Split Factor 1:300 Regular Market Day High 0.8423
Is_sp_500 False Profit Margins 0.00 % Fifty Two Week High 5.97
Day High 0.8423 Shares Short 534828 Regular Market Open 0.7563
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0148 Operating Cashflow -24126128 Currency USD
Time Zone Full Name America/New_York Market Cap 31 M Is_nasdaq_100 False
Zip V7T 2X1 Quote Type EQUITY Industry Biotechnology
Long Name BriaCell Therapeutics Corp. Regular Market Day Low 0.7400 Held Percent Institutions 0.0568
Current Price 0.8423 Address2 Suite 300 235 -15th Street Enterprise To Ebitda -0.4280
Financial Currency USD Current Ratio 0.49 Industry Disp Biotechnology
Number Of Analyst Opinions 2 Country Canada Float Shares 14 M
Two Hundred Day Average 1.48 Enterprise Value 14 M Forward PE -2.16
Regular Market Volume 1 M Ebitda -33246180 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
BriaCell Therapeutics Corp.

, a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer.

The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers.

It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer.

BriaCell Therapeutics Corp.

is based in West Vancouver, Canada.